| Technology Overview　GM-02 |
| Technology |
microRNA Biomarkers for Survival in Prognostic NSCLC Patients |
| Mechanism |
Specific microRNAs from Non-small cell lung cancer (NSCLC) |
| Application |
In Vitro Diagnosis, the prognostic markers for follow-on treatment on patients |
| Efficacy |
Occurrence validation study with 112 NSCLC clinical subjects |
| Development Stage |
Proto-type design Clinical validation with larger population |
| Intellectual Property |
U.S (Provisional filed @2007/04, regular filed @2008/4/9) |
| Collaboration Opportunity |
Technology licensing, Co-development, Research collaboration |
